Buy Aerie Pharmaceuticals Stock | AERI Stock Price & Latest News | Public
AERI

Aerie Pharmaceuticals

$0.00 (0.00%)Today

    About AERI

    Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.36
    -0.72
    -1.07
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.79

    Actual EPS
    Q4 2020

    Stats

    Market Cap$563,88M
    Volume23,74k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$26.26
    1 Year Low$9.01
    Open$12.20
    High$12.59
    Low$12.01

    Buy any stock with any amount of money.

    Download the App
    Download the app